GE builds diagnostics business with $587M Clarient buyout

GE on Friday announced plans to buy Clarient--a molecular diagnostics company with a strong focus on cancer markers--for $587 million. GE Healthcare is planning to build itself into a billion-dollar business marketing diagnostic solutions for healthcare providers. Story